Craig-Hallum initiated coverage of Cardiff Oncology with a Buy rating and $8 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on CRDF: Cardiff Oncology reports Q2 EPS (26c) vs. (25c) last year CRDF Upcoming Earnings Report: What to Expect? Disclaimer & DisclosureReport an Issue